Results 151 to 158 of about 37,128 (158)
A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease. [PDF]
J Prev Alzheimers DisGreeley D +11 more
europepmc +1 more source
Souffrir en silence : l’expérience d’une mère face à une erreur médicale. [PDF]
CMAJMacGregor L.
europepmc +1 more source
Perte auditive neurosensorielle subite. [PDF]
CMAJNewsted D, Bajin MD, You P.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Frontiers in Bioscience, 2005
Several membrane-bound molecules expressed at the surface of tumor cells have been shown to be released in a soluble form, thereby affecting cell-cell interactions by reduction of ligand densities. Moreover, since the binding domain of the soluble molecules often remains functional, proteolytic cleavage can also reduce the recognition of tumor cells by
openaire +3 more sources
Several membrane-bound molecules expressed at the surface of tumor cells have been shown to be released in a soluble form, thereby affecting cell-cell interactions by reduction of ligand densities. Moreover, since the binding domain of the soluble molecules often remains functional, proteolytic cleavage can also reduce the recognition of tumor cells by
openaire +3 more sources